Oncolysis of pancreatic tumour cells by a gamma34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI

F Sarinella1, A Calistri, P Sette

  • 1Department of Histology, Microbiology and Medical Biotechnologies, Section of Microbiology and Virology, Medical School, University of Padua, Padua, Italy.

Gene Therapy
|March 24, 2006
PubMed

Insights

Oncolytic viruses offer a promising cancer therapy. This study found that PI 3-kinase pathway dysregulation, not Ras signaling, enables replication-defective herpes simplex virus (HSV) to overcome antiviral defenses in pancreatic cancer cells.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Oncolysis, using viruses to destroy tumor cells, is a promising cancer therapy.
  • Pancreatic adenocarcinoma is aggressive and poorly responsive to conventional treatments.
  • Herpes simplex virus (HSV) shows oncolytic potential, particularly in Ras-overexpressing cells, common in pancreatic cancer.

Purpose of the Study:

  • To evaluate the potential of oncolytic viruses for pancreatic cancer treatment.
  • To investigate the role of Ras signaling and PKR activity in supporting herpes simplex virus replication in pancreatic cancer cells.
  • To identify cellular factors that permit replication of attenuated HSV-1 (R3616) in pancreatic cancer.

Main Methods:

  • Comparison of viral replication in four pancreatic cell lines with varying Ras signaling.
  • Assessment of viral permissiveness in relation to Ras pathway activation and PKR activity.
  • Investigation of the PI 3-kinase signaling pathway's role in viral replication.

Main Results:

  • Viral replication permissiveness in pancreatic cancer cells did not correlate with enhanced Ras signaling or defective PKR activity.
  • The PI 3-kinase signaling pathway was identified as a key factor enabling viral replication.
  • Dysregulation of the PI 3-kinase pathway allows the conditionally replication-defective R3616 HSV-1 strain to overcome cellular antiviral responses.

Conclusions:

  • Ras signaling and PKR activity are not the primary determinants of HSV replication in pancreatic cancer.
  • PI 3-kinase pathway dysregulation is crucial for overcoming cellular antiviral defenses and enabling oncolytic HSV replication in pancreatic cancer.
  • Targeting the PI 3-kinase pathway may enhance the efficacy of oncolytic herpes simplex virus therapy for pancreatic adenocarcinoma.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...